Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

24 Although the benefit of CAR T-cell therapy for multiple myeloma continues to outweigh the risk, vigilant monitoring for T-cell lymphoma should be implemented. Supported by Johnson & Johnson and ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.

director of the Cornell Center for Lymphoma and Myeloma at Weill Cornell Medical Center, tells WebMD. Lymphomas result when certain blood cells, called lymphocytes, multiply and refuse to obey ...

They are referred to as leukaemia, lymphoma and myeloma depending on the type of cell affected. The three types of malignancies are connected through the immune system and, generally, a disease ...

July 22, 2024 — The researchers report the ability of protein 'signatures' to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease ...

Residual disease can now be tracked in hematological malignancies, including leukemia, lymphoma and myeloma, and the benefits of these MRD tests have grown in tandem with their sensitivity and ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Pharma major, Biocon Pharma, has received final approvals from the U.S. Food and Drug Administration (FDA) for its ...